Medical and social care program for patients with psoriasis and/or psoriatic arthritis eligible for biological dmards in real clinical practice by L. S. Kruglova, T. V. Korotaeva

Get full text

Acneiform rash — skin toxic reaction to the use of EGFR inhibitors by E. A. Shatokhina, L. S. Kruglova

Get full text

Complete treatment experience on psoriasis patients with secukinumab in real practice in Krasnodar region by L. S. Kruglova, A. A. Khotko

Get full text

Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem by A. S. Polonskaia, E. A. Shatokhina, L. S. Kruglova

Get full text

Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 2 by N. O. Pereverzina, L. S. Kruglova, T. V. Korotaeva, A. M. Lila

Get full text

Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 1. by N. O. Pereverzina, L. S. Kruglova, T. V. Korotaeva, A. M. Lila

Get full text

Specificity of hand-foot skin reaction induced by multikinase inhibitors: clinical, histological and ultrasound characteristics by E. A. Shatokhina, S. B. Potkin, P. G. Malkov, L. S. Kruglova, A. S. Polonskaya

Get full text

Combination of ankylosing spondylitis with combined autoinflammatory skin lesions (clinical observation and literature review) by D. A. Dibrov, T. V. Korotaeva, S. O. Krasnenko, M. M. Urumova, L. S. Kruglova, A. M. Lila

Get full text

Combination of ankylosing spondylitis with combined autoinflammatory skin lesions. Clinical case and review by D. A. Dibrov, T. V. Korotaeva, S. O. Krasnenko, M. M. Urumova, L. S. Kruglova, A. M. Lila

Get full text

Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction by A. V. Michenko, L. S. Kruglova, E. A. Shatokhina, I. B. Kononenko, A. S. Polonskaya, D. V. Romanov

Get full text

Draft interdisciplinary guidelines for diagnosis, methods for estimation of the degree of activity, for evaluation of therapeutic efficacy, and for use of biological agents in pati... by D. I. Abdulganieva, A. L. Bakulev, E. А. Belousova, L. F. Znamenskaya, T. V. Korotaeva, L. S. Kruglova, M. M. Kokhan, A. M. Lila, V. R. Khairutdinov, I. L. Khalif, M. M. Khobeish

Get full text

THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT by V. A. Gorbunova, E. A. Pigarova, L. Ya. Rozhinskaya, I. A. Voronkova, Yu. A. Krupinova, G. S. Emel’yanova, L. S. Kruglova, S. V. Shiryaev, M. B. Dolgushin, M. E. Bilik, E. A. Kobyakova, D. V. Komov

Get full text

Consensus document APAIR: atopic dermatitis in children — update 2019 (short version) Part 2. by Yu. S. Smolkin, I. I. Balabolkin, I. A. Gorlanov, L. S. Kruglova, A. V. Kudryavtseva, R. Y. Meshkova, H. B. Migacheva, R. F. Khakimova, A. A. Cheburkin, E. A. Kuropatnikova, N. A. Lyan, A. V. Maksimova, S. S. Masalskiy, O. Y. Smolkina

Get full text

Consensus document APAIR: atopic dermatitis in children — update 2019 (short version) Part 1. by Yu. S. Smolkin, I. I. Balabolkin, I. A. Gorlanov, L. S. Kruglova, A. V. Kudryavtseva, R. Y. Meshkova, H. B. Migacheva, R. F. Khakimova, A. A. Cheburkin, E. A. Kuropatnikova, N. A. Lyan, A. V. Maksimova, S. S. Masalskiy, O. Y. Smolkina

Get full text